Sankala Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Sankala Group's ELV Position: Q1 2026 in Review
Sankala Group reduced its Elevance Health (ELV) stake by 26% in Q1 2026, selling an estimated $1.64K and leaving 14 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #445.
Sankala Group first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.08K in Q4 2025. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Sankala Group held 14 shares of Elevance Health worth $4.03K as of Q1 2026.
- Sankala Group sold 5 Elevance Health shares in Q1 2026, an estimated $1.64K.
- Elevance Health made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #445 holding.
- Sankala Group first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
- Sankala Group's Elevance Health position peaked at $6.08K in Q4 2025.
- 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.